ANI PHARMACEUTICALS INC (ANIP)
Pharmaceutical Preparations
Latest Price
$79.24
TTM P/E
20.27
Normalized P/E
--
Div Yield
--
Book Value
26.89
P/B Ratio
2.95
Valuation metrics
adjust assumptions →EPS: $3.32
Book value / share: $24.04
Formula: √(22.5 × EPS × BVPS)
Graham Number
$42.38
47% downside
Base FCF: $79M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$14.67
81% downside
EPS: $3.32
Target P/E: 20×
Formula: EPS × P/E
P/E Fair Value
$66.40
16% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.75M | $211.0M | 13.14% | +85.8K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 823.1K | $63.0M | 3.94% | -- | 2026-03-31 |
| Soleus Capital Management, L.P. | 820.2K | $63.0M | 3.92% | +334.0K | 2026-03-31 |
| STATE STREET CORP | 771.6K | $59.0M | 3.69% | +44.4K | 2026-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 707.5K | $54.0M | 3.38% | +226.1K | 2026-03-31 |
| GOLDENTREE ASSET MANAGEMENT LP | 668.0K | $51.0M | 3.19% | -- | 2026-03-31 |
| Deep Track Capital, LP | 600.0K | $46.0M | 2.87% | +122.3K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 592.0K | $45.0M | 2.83% | +52.3K | 2026-03-31 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 564.4K | $43.0M | 2.70% | +91.2K | 2026-03-31 |
| Caption Management, LLC | 535.9K | $41.0M | 2.56% | +278.1K | 2026-03-31 |